
Impact of COVID-19 pandemic and lockdowns on the consumption of anxiolytics, hypnotics and antidepressants according to age groups: a French nationwide study
Author(s) -
Maurice Levaillant,
Marielle Wathelet,
Antoine Lamer,
Élise Riquin,
Bénédicte Gohier,
J-F Hamel-Broza
Publication year - 2021
Publication title -
psychological medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.857
H-Index - 209
eISSN - 1469-8978
pISSN - 0033-2917
DOI - 10.1017/s0033291721004839
Subject(s) - pandemic , mental health , context (archaeology) , public health , medicine , epidemiology , population , consumption (sociology) , covid-19 , demography , psychiatry , environmental health , geography , disease , infectious disease (medical specialty) , social science , nursing , archaeology , pathology , sociology
Previous studies have shown a negative impact of the COVID-19 pandemic and its associated sanitary measures on mental health, especially among adolescents and young adults. Such a context may raise many concerns about the COVID-19 pandemic long-term psychological effects. An analysis of administrative databases could be an alternative and complementary approach to medical interview-based epidemiological surveys to monitor the mental health of the population. We conducted a nationwide study to describe the consumption of anxiolytics, antidepressants and hypnotics during the first year of the COVID-19 pandemic, compared to the five previous years.